BioCentury
ARTICLE | Strategy

Gensia plans to cash out Aramed

June 19, 1995 7:00 AM UTC

Gensia Inc. ended the suspense for its Aramed Inc. shareholders, announcing on Friday an agreement under which GNSA will acquire ARAM for about $37.4 million, far less than the $159 million GNSA would have owed at the end of this year under the companies' 1991 agreement.

On a per share basis, ARAM shareholders will get about $12.50-$13, rather than the $55.40 originally envisioned...